Document Type
Article
Publication Date
2-27-2020
Abstract
The National Center for Posttraumatic Stress Disorder (PTSD) reported approximately seven to eight people out of 100 will develop PTSD at some point in their lives and an estimated eight million adults will develop PTSD during a given year. It is also estimated between 55-60% of persons diagnosed with PTSD are diagnosed with a substance-use disorder (SUD). However, despite clinical guidelines that increasingly recommend the use of psychotherapies within the same treatment episode for clients with comorbid SUD/PTSD and client preferences for combined PTSD/SUD treatment, clinicians tend to overlook comorbid trauma and substance issues and/or are inclined to provide separate treatment for comorbid trauma and substance-related issues. This review is designed to provide a synopsis of the most effective, evidence-based psychotherapeutic treatments for comorbid PTSD/SUD, with emphasis on recent advancements in mindfulness approaches. The review also discusses ketamine infusion therapy (KIT), a newly developed psychopharmacological approach for treatment-resistant PTSD and comorbid SUD.
Recommended Citation
Ortega, C. L., & Miller, E. (2020). Comorbid Posttraumatic Stress and Substance Use Disorders: Treatment Guidelines for Counselors. Open Access Journal of Addiction and Psychology, 3(3), 1-7. http://doi.org/10.33552/OAJAP.2020.03.000565
Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.
DOI
http://doi.org/10.33552/OAJAP.2020.03.000565
Comments
Copyright The Authors. This work is licensed under Creative Commons Attribution 4.0 License